European Medicines Agency Will Review Marketing Application for Niraparib to Treat Ovarian Cancer
News
The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) of niraparib for the treatment of platinum-sensitive ovarian cancer patients, according to Tesaro, the product manufacturer. ... Read more